Emergent BioSolutions Inc. (EBS)

NYQ – Цена в реальном времени. Валюта: USD

4.56

+0.11 (2.44%)

Рынок открыт: Aug 12, 2026, 2:12 PM EDT

4.46

+0.01 (0.22%)

Предыдущая сессия: Aug 11, 2026, 7:57 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Emergent BioSolutions Inc. (EBS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Emergent BioSolutions Inc. (EBS)

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent Biosolutions Q2 Earnings Call Highlights

Emergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call Transcript

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Search stocks

Emergent BioSolutions Inc. (EBS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Emergent BioSolutions Inc. (EBS)

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent Biosolutions Q2 Earnings Call Highlights

Emergent BioSolutions Inc. (EBS) Q2 2026 Earnings Call Transcript

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

EBS Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions Reports Second Quarter 2026 Financial Results